SCHEMBL3847151

SCHEMBL3847151

CS(=O)(=O)c1ccc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(C#N)cc4)cn23)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 10/20 0.41
PIK3CA P42336 1/20 0.35
MKNK1 Q9BUB5 3/20 0.34
MKNK2 Q9HBH9 3/20 0.34
CYP3A4 P08684 1/20 0.34
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
NTRK1 P04629 2/20 0.34
NTRK3 Q16288 2/20 0.34
NTRK2 Q16620 2/20 0.34
JAK2 O60674 1/20 0.33
ABL1 P00519 1/20 0.33
INSR P06213 1/20 0.33
LCK P06239 1/20 0.33
CSF1R P07333 1/20 0.33
LYN P07948 1/20 0.33
RET P07949 1/20 0.33
IGF1R P08069 1/20 0.33
MET P08581 1/20 0.33
ROS1 P08922 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846437 0.90 FLT3 (0.51) FLT3AKT1AKT2KCNH2TGFBR1
SCHEMBL3847243 0.88 FLT3 (0.41) FLT3MKNK1MKNK2AKT1AKT2
SCHEMBL3848269 0.86 KCNH2 (0.48) FLT3PIK3CAMKNK1MKNK2CYP3A4
SCHEMBL3848127 0.86 FLT3 (0.40) FLT3MKNK1MKNK2AKT1AKT2
SCHEMBL3846126 0.86 FLT3 (0.42) FLT3KCNH2TGFBR1
SCHEMBL3847153 0.85 FLT3 (0.35) FLT3PIK3CAMKNK1MKNK2CYP3A4
SCHEMBL3850040 0.85 FLT3 (0.45) FLT3MKNK1MKNK2KCNH2TGFBR1
SCHEMBL3848234 0.85 MKNK1 (0.41) FLT3PIK3CAMKNK1MKNK2JAK2
SCHEMBL3845273 0.84 FLT3 (0.47) FLT3PIK3CAKCNH2TGFBR1
SCHEMBL3847887 0.83 FLT3 (0.43) FLT3MKNK1MKNK2KCNH2EIF4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed